HUTCHMED to Present R&D Updates on October 31 2025

Summary by AI BETAClose X

HUTCHMED will host a Research & Development update on Friday, October 31, 2025, in Shanghai and via webcast. The event will feature insights into the company's R&D strategy from Dr. Michael Shi, focusing on the Antibody Targeted Therapy Conjugates platform and its lead candidate HMPL-A251, along with updates on late-stage pipeline development. The in-person Shanghai event will be from 3:00 p.m. to 5:00 p.m. HKT and conducted in Chinese, with a concurrent live webcast. An English webcast will be held at 8:00 p.m. HKT / 8:00 a.m. EDT / 12:00 noon GMT on the same day, lasting approximately one hour. Both webcasts and a replay will be available on the company website.

Disclaimer*

UK 100

Latest directors dealings